Stapled peptide PROTAC induced significantly greater anti-PD-L1 effects than inhibitor in human cervical cancer cells

INTRODUCTION: Immune checkpoint inhibitors (ICIs) are monoclonal antibodies that target immune checkpoints that suppress immune cell activity. Low efficiency and high resistance are currently the main barriers to their clinical application. As a representative technology of targeted protein degradat...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Yu-Ying, Wang, An-Jin, Liu, Xue-Lian, Dai, Meng-Yuan, Cai, Hong-Bing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10262918/
https://www.ncbi.nlm.nih.gov/pubmed/37325638
http://dx.doi.org/10.3389/fimmu.2023.1193222

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10262918/
https://www.ncbi.nlm.nih.gov/pubmed/37325638
http://dx.doi.org/10.3389/fimmu.2023.1193222

Ejemplares similares